Ann: Appendix 4C - Quarterly - 31 March 2025, page-6

  1. 23,776 Posts.
    lightbulb Created with Sketch. 2468
    Balance. Accordingly the main operations of the Company at present are business development and capital attraction. The Company has been in discussions with multiple strategic investors to fund internal product development, as well as with third parties who are interested in developing novel therapeutics that target the NETosis pathway.
    While these discussions have been encouraging, they have been tempered by the current
    macroeconomic trends that are impacting deal-making globally.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.1¢
Change
-0.001(33.3%)
Mkt cap ! $2.365M
Open High Low Value Volume
0.1¢ 0.1¢ 0.1¢ $75 75K

Buyers (Bids)

No. Vol. Price($)
35 152028049 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 70691290 20
View Market Depth
Last trade - 15.47pm 07/08/2025 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.